Regulation of PDGF and its receptors in fibrotic diseases

Heldin, 2002, New members of the platelet-derived growth factor family of mitogens, Arch. Biochem. Biophys., 398, 284, 10.1006/abbi.2001.2707 Bonner, 1995, Cytokine-binding proteins in the lung, Am. J. Physiol., 268, L869 Schwarz MI, King TE. Interstitial lung disease. Philadelphia, PA: BC Decker Inc.; 1988. 350 p. Martinet, 1986, Activated human monocytes express the c-sis proto-oncogene and release a mediator showing PDGF-like activity, Nature, 319, 158, 10.1038/319158a0 Martinet, 1987, Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis, N. Engl. J. Med., 317, 202, 10.1056/NEJM198707233170404 Antoniades, 1990, Platelet-derived growth factor in idiopathic pulmonary fibrosis, J. Clin. Invest., 86, 1055, 10.1172/JCI114808 Vignaud, 1991, Presence of platelet-derived growth factor in normal and fibrotic lung is specifically associated with interstitial macrophages, while both interstitial macrophages and alveolar epithelial cells express the c-sis proto-oncogene, Am. J. Respir. Cell. Mol. Biol., 5, 531, 10.1165/ajrcmb/5.6.531 Homma, 1995, Localization of platelet-derived growth factor and insulin-like growth factor I in the fibrotic lung, Am. J. Respir. Crit. Care Med., 152, 2084, 10.1164/ajrccm.152.6.8520779 Nagaoka, 1990, Upregulation of platelet-derived growth factor-A and -B gene expression in alveolar macrophages of individuals with idiopathic pulmonary fibrosis, J. Clin. Invest., 85, 2023, 10.1172/JCI114669 Hertz, 1992, Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor, Proc. Natl. Acad. Sci. U.S.A., 89, 10385, 10.1073/pnas.89.21.10385 Bergmann, 1998, Gene expression of profibrotic mediators in bronchiolitis obliterans syndrome after lung transplantation, Scand. Cardiovasc. J., 32, 97, 10.1080/14017439850140247 Harmon, 1994, Pathogenesis of pulmonary fibrosis: platelet-derived growth factor precedes structural alterations in the Hermansky–Pudlak syndrome, J. Lab. Clin. Med., 123, 617 Shimokado, 1985, A significant part of macrophage-derived growth factor consists of at least two forms of PDGF, Cell, 43, 277, 10.1016/0092-8674(85)90033-9 Rom, 1991, Cellular and molecular basis of the asbestos-related diseases, Am. Rev. Respir. Dis., 143, 408, 10.1164/ajrccm/143.2.408 Vanhee, 1994, Mechanisms of fibrosis in coal workers’ pneumoconiosis. Increased production of platelet-derived growth factor, insulin-like growth factor type I, and transforming growth factor beta and relationship to disease severity, Am. J. Respir. Crit. Care Med., 150, 1049, 10.1164/ajrccm.150.4.7921435 Fabisiak, 1989, Increased expression of PDGF-B (c-sis) mRNA in rat lung precedes DNA synthesis and tissue repair during chronic hyperoxia, Am. J. Respir. Cell. Mol. Biol., 1, 181, 10.1165/ajrcmb/1.3.181 Walsh, 1993, Variable expression of platelet-derived growth factor family proteins in acute lung injury, Am. J. Respir. Cell. Mol. Biol., 9, 637, 10.1165/ajrcmb/9.6.637 Liu, 1997, Rapid activation of PDGF-A and -B expression at sites of lung injury in asbestos-exposed rats, Am. J. Respir. Cell. Mol. Biol., 17, 129, 10.1165/ajrcmb.17.2.2956 Bonner, 1991, Differential proliferation of rat lung fibroblasts induced by the platelet-derived growth factor-AA, -AB, and -BB isoforms secreted by rat alveolar macrophages, Am. J. Respir. Cell. Mol. Biol., 5, 539, 10.1165/ajrcmb/5.6.539 Osornio-Vargas, 1990, Rat alveolar macrophage-derived platelet-derived growth factor is chemotactic for rat lung fibroblasts, Am. J. Respir. Cell. Mol. Biol., 3, 595, 10.1165/ajrcmb/3.6.595 Osornio-Vargas, 1995, Platelet-derived growth factor (PDGF)-AA, -AB, and -BB induce differential chemotaxis of early-passage rat lung fibroblasts in vitro, Am. J. Respir. Cell. Mol. Biol., 12, 33, 10.1165/ajrcmb.12.1.7811469 Lasky, 1995, Chrysotile asbestos stimulates platelet-derived growth factor-AA production by rat lung fibroblasts in vitro: evidence for an autocrine loop, Am. J. Respir. Cell. Mol. Biol., 12, 162, 10.1165/ajrcmb.12.2.7865215 Bonner, 1993, Chrysotile asbestos upregulates gene expression and production of alpha-receptors for platelet-derived growth factor (PDGF-AA) on rat lung fibroblasts, J. Clin. Invest., 92, 425, 10.1172/JCI116584 Li, 2000, PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor, Nat. Cell Biol., 2, 302, 10.1038/35010579 Zhuo, 2004, Modulation of PDGF-C and PDGF-D expression during bleomycin-induced lung fibrosis, Am. J. Physiol. Lung Cell Mol. Physiol., 286, L182, 10.1152/ajplung.00083.2003 Shaw, 1991, Pathogenesis of pulmonary fibrosis in interstitial lung disease. Alveolar macrophage PDGF(B) gene activation and up-regulation by interferon gamma, Am. Rev. Respir. Dis., 143, 167, 10.1164/ajrccm/143.1.167 Ramana, 2001, Stat1-independent regulation of gene expression in response to IFN-gamma, Proc. Natl. Acad. Sci. U.S.A., 98, 6674, 10.1073/pnas.111164198 Raines, 1989, Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA, Science, 243, 393, 10.1126/science.2783498 Kolb, 2001, Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis, J. Clin. Invest., 107, 1529, 10.1172/JCI12568 Ingram, 2003, Interleukin-13 stimulates the proliferation of lung myofibroblasts via a signal transducer and activator of transcription-6-dependent mechanism: a possible mechanism for the development of airway fibrosis in asthma, Chest, 123, 422S, 10.1378/chest.123.3_suppl.422S Bostrom, 1996, PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis, Cell, 85, 863, 10.1016/S0092-8674(00)81270-2 Hoyle, 1999, Emphysematous lesions, inflammation, and fibrosis in the lungs of transgenic mice overexpressing platelet-derived growth factor, Am. J. Pathol., 154, 1763, 10.1016/S0002-9440(10)65432-6 Yoshida, 1995, A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene, Proc. Natl. Acad. Sci. U.S.A., 92, 9570, 10.1073/pnas.92.21.9570 Yi, 1996, Platelet-derived growth factor causes pulmonary cell proliferation and collagen deposition in vivo, Am. J. Pathol., 149, 539 Bonner, 1998, Induction of PDGF receptor-alpha in rat myofibroblasts during pulmonary fibrogenesis in vivo, Am. J. Physiol., 274, L72 Lasky, 1998, Upregulation of the PDGF-alpha receptor precedes asbestos-induced lung fibrosis in rats, Am. J. Respir. Crit. Care Med., 157, 1652, 10.1164/ajrccm.157.5.9704116 Coin, 1996, Lipopolysaccharide up-regulates platelet-derived growth factor (PDGF) alpha-receptor expression in rat lung myofibroblasts and enhances response to all PDGF isoforms, J. Immunol., 156, 4797, 10.4049/jimmunol.156.12.4797 Bonner, 1998, Induction of the lung myofibroblast PDGF receptor system by urban ambient particles from Mexico City, Am. J. Respir. Cell. Mol. Biol., 19, 672, 10.1165/ajrcmb.19.4.3176 Lindroos, 1995, Interleukin 1 beta (IL-1 beta) and the IL-1 beta-alpha 2-macroglobulin complex upregulate the platelet-derived growth factor alpha-receptor on rat pulmonary fibroblasts, Am. J. Respir. Cell. Mol. Biol., 13, 455, 10.1165/ajrcmb.13.4.7546776 Lindroos, 1997, Alveolar macrophages stimulated with titanium dioxide, chrysotile asbestos, and residual oil fly ash upregulate the PDGF receptor-alpha on lung fibroblasts through an IL-1beta-dependent mechanism, Am. J. Respir. Cell. Mol. Biol., 16, 283, 10.1165/ajrcmb.16.3.9070613 Osornio-Vargas, 1996, Maximal PDGF-induced lung fibroblast chemotaxis requires PDGF receptor-alpha, Am. J. Physiol., 271, L93 Seifert, 1993, PDGF-AB requires PDGF receptor alpha-subunits for high-affinity, but not for low-affinity, binding and signal transduction, J. Biol. Chem., 268, 4473, 10.1016/S0021-9258(18)53633-4 Rupp, 1994, A unique autophosphorylation site in the platelet-derived growth factor alpha receptor from a heterodimeric receptor complex, Eur. J. Biochem., 225, 29, 10.1111/j.1432-1033.1994.00029.x Wang, 2000, Regulation of interleukin-1beta -induced platelet-derived growth factor receptor-alpha expression in rat pulmonary myofibroblasts by p38 mitogen-activated protein kinase, J. Biol. Chem., 275, 22550, 10.1074/jbc.M909785199 Lindroos, 1998, Role of nuclear factor-kappa B and mitogen-activated protein kinase signaling pathways in IL-1 beta-mediated induction of alpha-PDGF receptor expression in rat pulmonary myofibroblasts, J. Immunol., 161, 3464, 10.4049/jimmunol.161.7.3464 Lindroos, 2001, Regulation of PDGFR-alpha in rat pulmonary myofibroblasts by staurosporine, Am. J. Physiol. Lung Cell Mol. Physiol., 280, L354, 10.1152/ajplung.2001.280.2.L354 Fukuoka, 1999, Transcriptional regulation of the platelet-derived growth factor alpha receptor gene via CCAAT/enhancer-binding protein-delta in vascular smooth muscle cells, J. Biol. Chem., 274, 25576, 10.1074/jbc.274.36.25576 Tsukamoto, 1991, Interleukin-1 enhances the response of osteoblasts to platelet-derived growth factor through the alpha receptor-specific up-regulation, J. Biol. Chem., 266, 10143, 10.1016/S0021-9258(18)99201-X Yeh, 1993, IL-1 and transforming growth factor-beta inhibit platelet-derived growth factor-AA binding to osteoblastic cells by reducing platelet-derived growth factor-alpha receptor expression, J. Immunol., 150, 5625, 10.4049/jimmunol.150.12.5625 Ohba, 1994, Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor, Am. J. Respir. Cell. Mol. Biol., 10, 405, 10.1165/ajrcmb.10.4.7510986 Bonner, 1996, Basic fibroblast growth factor induces expression of the PDGF receptor-alpha on human bronchial smooth muscle cells, Am. J. Physiol., 271, L880 Bonner, 1995, Transforming growth factor beta 1 downregulates the platelet-derived growth factor alpha-receptor subtype on human lung fibroblasts in vitro, Am. J. Respir. Cell. Mol. Biol., 13, 496, 10.1165/ajrcmb.13.4.7546780 Boyle, 1999, Prostaglandin-E2 counteracts interleukin-1beta-stimulated upregulation of platelet-derived growth factor alpha-receptor on rat pulmonary myofibroblasts, Am. J. Respir. Cell. Mol. Biol., 20, 433, 10.1165/ajrcmb.20.3.3284 Bonner, 2002, Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis, Am. J. Pathol., 161, 459, 10.1016/S0002-9440(10)64202-2 Reif, 2003, The role of focal adhesion kinasephosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression, J. Biol. Chem., 278, 8083, 10.1074/jbc.M212927200 Simon, 1998, Activation of the JAK-STAT pathway by reactive oxygen species, Am. J. Physiol., 275, C1640, 10.1152/ajpcell.1998.275.6.C1640 Rice, 2002, p38 mitogen-activated protein kinase regulates growth factor-induced mitogenesis of rat pulmonary myofibroblasts, Am. J. Respir. Cell. Mol. Biol., 27, 759, 10.1165/rcmb.2002-0070OC Friedman, 2000, Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury, J. Biol. Chem., 275, 2247, 10.1074/jbc.275.4.2247 Friedman, 2003, Liver fibrosis—from bench to bedside, J. Hepatol., 38, S38, 10.1016/S0168-8278(02)00429-4 Friedman, 1989, Activation of cultured rat hepatic lipocytes by Kupffer cell conditioned medium. Direct enhancement of matrix synthesis and stimulation of cell proliferation via induction of platelet-derived growth factor receptors, J. Clin. Invest., 84, 1780, 10.1172/JCI114362 Pinzani, 1989, Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells, J. Clin. Invest., 84, 1786, 10.1172/JCI114363 Pinzani, 1995, Transforming growth factor-beta 1 regulates platelet-derived growth factor receptor beta subunit in human liver fat-storing cells, Hepatology, 21, 232 Bissell, 1995, Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation, J. Clin. Invest., 96, 447, 10.1172/JCI118055 Wong, 1994, Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture, J. Clin. Invest., 94, 1563, 10.1172/JCI117497 Pinzani, 1996, Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis, Am. J. Pathol., 148, 785 Ikura, 1997, Expression of platelet-derived growth factor and its receptor in livers of patients with chronic liver disease, J. Gastroenterol., 32, 496, 10.1007/BF02934089 Pinzani, 2001, Cytokine receptors and signaling in hepatic stellate cells, Semin. Liver Dis., 21, 397, 10.1055/s-2001-17554 Pinzani, 2002, PDGF and signal transduction in hepatic stellate cells, Front Biosci., 7, d1720, 10.2741/pinzani Pages, 1993, Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation, Proc. Natl. Acad. Sci. U.S.A., 90, 8319, 10.1073/pnas.90.18.8319 Marra, 1999, Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor’s actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat, Hepatology, 30, 951, 10.1002/hep.510300406 Marra, 1997, Phosphatidylinositol 3-kinase is required for platelet-derived growth factor’s actions on hepatic stellate cells, Gastroenterology, 112, 1297, 10.1016/S0016-5085(97)70144-6 Carloni, 2000, Tyrosine phosphorylation of focal adhesion kinase by PDGF is dependent on ras in human hepatic stellate cells, Hepatology, 31, 131, 10.1002/hep.510310121 Carloni, 2002, Cell adhesion regulates platelet-derived growth factor-induced MAP kinase and PI-3 kinase activation in stellate cells, Hepatology, 36, 582, 10.1053/jhep.2002.35277 Pinzani, 1991, Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells, Am. J. Physiol., 260, C485, 10.1152/ajpcell.1991.260.3.C485 Failli, 1995, The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx, Am. J. Physiol., 269, C1133, 10.1152/ajpcell.1995.269.5.C1133 Mallat, 1998, Platelet-derived growth factor-BB and thrombin generate positive and negative signals for human hepatic stellate cell proliferation. Role of a prostaglandin/cyclic AMP pathway and cross-talk with endothelin receptors, J. Biol. Chem., 273, 27300, 10.1074/jbc.273.42.27300 Graves, 1993, Protein kinase A antagonizes platelet-derived growth factor-induced signaling by mitogen-activated protein kinase in human arterial smooth muscle cells, Proc. Natl. Acad. Sci. U.S.A., 90, 10300, 10.1073/pnas.90.21.10300 Pinzani, 1996, Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells, Br. J. Pharmacol., 119, 1117, 10.1111/j.1476-5381.1996.tb16012.x Mallat, 1995, Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells. An endothelin B receptor-mediated pathway, J. Clin. Invest., 96, 42, 10.1172/JCI118052 Paradis, 2002, Effects and regulation of connective tissue growth factor on hepatic stellate cells, Lab. Invest., 82, 767, 10.1097/01.LAB.0000017365.18894.D3 Paradis, 1999, Expression of connective tissue growth factor in experimental rat and human liver fibrosis, Hepatology, 30, 968, 10.1002/hep.510300425 Frazier, 1996, Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor, J. Invest. Dermatol., 107, 404, 10.1111/1523-1747.ep12363389 Harris, 2003, Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies, Curr. Opin. Rheumatol., 15, 778, 10.1097/00002281-200311000-00016 Medsger Jr TA. Systemic sclerosis (scleroderma), localized forms of scleroderma, and calcinosis. In: McCarty DJ, Koopman WJ, editors. Arthritis and allied conditions. Philadelphia, PA: Lea & Febiger; 1993. p. 1253–92. Atamas, 2003, Cytokine regulation of pulmonary fibrosis in scleroderma, Cytokine Growth Factor Rev., 4, 537, 10.1016/S1359-6101(03)00060-1 LeRoy, 1974, Increased collagen synthesis by scleroderma skin fibroblasts in vitro: a possible defect in the regulation or activation of the scleroderma fibroblast, J. Clin. Invest., 54, 880, 10.1172/JCI107827 Buckingham, 1978, Increased collagen accumulation in dermal fibroblast cultures from patients with progressive systemic sclerosis (scleroderma), J. Lab. Clin. Med., 92, 5 Jelaska, 2000, Role of apoptosis and transforming growth factor beta1 in fibroblast selection and activation in systemic sclerosis, Arthritis Rheum., 43, 2230, 10.1002/1529-0131(200010)43:10<2230::AID-ANR10>3.0.CO;2-8 Santiago, 2001, Decreased susceptibility to Fas-induced apoptosis of systemic sclerosis dermal fibroblasts, Arthritis Rheum., 44, 1667, 10.1002/1529-0131(200107)44:7<1667::AID-ART291>3.0.CO;2-Y Gay, 1989, Immunohistologic demonstration of platelet-derived growth factor (PDGF) and sis-oncogene expression in scleroderma, J. Invest. Dermatol., 92, 301, 10.1111/1523-1747.ep12276895 Klareskog, 1990, Increased expression of platelet-derived growth factor type B receptors in the skin of patients with systemic sclerosis, Arthritis Rheum., 33, 1534, 10.1002/art.1780331011 Pandolfi, 1989, Increased plasma levels of platelet-derived growth factor activity in patients with progressive systemic sclerosis, Proc. Soc. Exp. Biol. Med., 191, 1, 10.3181/00379727-191-42880 Ludwicka, 1995, Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma, J. Rheumatol., 22, 1876 Kawaguchi, 1994, IL-1 alpha gene expression and protein production by fibroblasts from patients with systemic sclerosis, Clin. Exp. Immunol., 97, 445, 10.1111/j.1365-2249.1994.tb06108.x Kawaguchi, 1999, Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A, J. Clin. Invest., 103, 1253, 10.1172/JCI4304 Takemura, 1998, Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor, J. Rheumatol., 25, 1534 Yamakage, 1992, Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblasts, J. Exp. Med., 175, 1227, 10.1084/jem.175.5.1227 Ichiki, 1995, Different effects of basic fibroblast growth factor and transforming growth factor-beta on the two platelet-derived growth factor receptors’ expression in scleroderma and healthy human dermal fibroblasts, J. Invest. Dermatol., 104, 124, 10.1111/1523-1747.ep12613617 Kikuchi, 1995, Growth regulation in scleroderma fibroblasts: increased response to transforming growth factor-beta 1, J. Invest. Dermatol., 105, 128, 10.1111/1523-1747.ep12313452 Battegay, 1990, TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop, Cell, 63, 515, 10.1016/0092-8674(90)90448-N Dong, 2002, Deficient Smad7 expression: a putative molecular defect in scleroderma, PNAS, 99, 3908, 10.1073/pnas.062010399 Zhou, 2002, Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma, Arthritis Rheum., 46, 2990, 10.1002/art.10601 Ostendorf, 2001, Specific antagonism of PDGF prevents renal scarring in experimental glomerulonephritis, J. Am. Soc. Nephrol., 12, 909, 10.1681/ASN.V125909 Slomowitz, 1988, Progression of renal disease, N. Engl. J. Med., 319, 1547, 10.1056/NEJM198812083192312 Alpers, 1992, Developmental patterns of PDGF B-chain, PDGF-receptor, and alpha-actin expression in human glomerulogenesis, Kidney Int., 42, 390, 10.1038/ki.1992.300 Abboud, 1995, Role of platelet-derived growth factor in renal injury, Annu. Rev. Physiol., 57, 297, 10.1146/annurev.ph.57.030195.001501 Yoshimura, 1991, Demonstration of PDGF B-chain mRNA in glomeruli in mesangial proliferative nephritis by in situ hybridization, Kidney Int., 40, 470, 10.1038/ki.1991.234 Floege, 1993, Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor B-chain, Am. J. Pathol., 142, 637 Floege, 1998, Expression of PDGF alpha-receptor in renal arteriosclerosis and rejecting renal transplants, J. Am. Soc. Nephrol., 9, 211, 10.1681/ASN.V92211 Bhandari, 1994, Platelet-derived growth factor (PDGF) BB homodimer regulates PDGF A- and PDGF B-chain gene transcription in human mesangial cells, Biochem. J., 297, 385, 10.1042/bj2970385 Kohno, 1999, Regulation of rat mesangial cell migration by platelet-derived growth factor, angiotensin II, and adrenomedullin, J. Am. Soc. Nephrol., 10, 2495, 10.1681/ASN.V10122495 Floege, 1993, Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats, J. Clin. Invest., 92, 2952, 10.1172/JCI116918 Tang, 1996, Platelet-derived growth factor-BB induces renal tubulointerstitial myofibroblast formation and tubulointerstitial fibrosis, Am. J. Pathol., 148, 1169 Fraser, 2002, Independent regulation of transforming growth factor-beta1 transcription and translation by glucose and platelet-derived growth factor, Am. J. Pathol., 161, 1039, 10.1016/S0002-9440(10)64265-4 Yamabe, 2000, Platelet-derived growth factor, basic fibroblast growth factor, and interferon gamma increase type IV collagen production in human fetal mesangial cells via a transforming growth factor-beta-dependent mechanism, Nephrol. Dial Transplant., 15, 872, 10.1093/ndt/15.6.872 Phillips, 1995, Elevated d-glucose concentrations modulate TGF-beta 1 synthesis by human cultured renal proximal tubular cells. The permissive role of platelet-derived growth factor, Am. J. Pathol., 147, 362 Johnson, 1992, Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor, J. Exp. Med., 175, 1413, 10.1084/jem.175.5.1413 Floege, 1999, Novel approach to specific growth factor inhibition in vivo: antagonism of platelet-derived growth factor in glomerulonephritis by aptamers, Am. J. Pathol., 154, 169, 10.1016/S0002-9440(10)65263-7 Leveen, 1994, Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities, Genes Dev., 8, 1875, 10.1101/gad.8.16.1875 Soriano, 1994, Abnormal kidney development and hematological disorders in PDGF beta-receptor mutant mice, Genes Dev., 8, 1888, 10.1101/gad.8.16.1888 Langham, 2003, Over-expression of platelet-derived growth factor in human diabetic nephropathy, Nephrol. Dial Transplant., 18, 1392, 10.1093/ndt/gfg177 Liapis, 1997, Increased expression of platelet-derived growth factor A and collagenous matrix proteins in congenital multicystic renal dysplasia, Nephronology, 76, 161, 10.1159/000190164 Ricono, 2002, Effect of platelet-derived growth factor isoforms in rat metanephric mesenchymal cells, Am. J. Physiol. Renal. Physiol., 282, F211, 10.1152/ajprenal.0323.2000 Wallmon, 1993, PDGF-BB, but not PDGF-AA, stimulates calcium mobilization, activation of calcium channels and cell proliferation in cultured rat mesangial cells, Exp. Nephrol., 1, 238 Eitner, 2002, Expression of a novel PDGF isoform, PDGF-C, in normal and diseased rat kidney, J. Am. Soc. Nephrol., 13, 910, 10.1681/ASN.V134910 Eitner, 2003, ERCB-Consortium. PDGF-C expression in the developing and normal adult human kidney and in glomerular diseases, J. Am. Soc. Nephrol., 14, 1145, 10.1097/01.ASN.0000062964.75006.A8 Bergsten, 2001, PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor, Nat. Cell Biol., 3, 512, 10.1038/35074588 LaRochelle, 2001, PDGF-D, a new protease-activated growth factor, Nat. Cell Biol., 3, 517, 10.1038/35074593 Ostendorf, 2003, A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis, J. Am. Soc. Nephrol., 14, 2237, 10.1097/01.ASN.0000083393.00959.02 Taneda, 2003, Obstructive uropathy in mice and humans: potential role for PDGF-D in the progression of tubulointerstitial injury, J. Am. Soc. Nephrol., 14, 2544, 10.1097/01.ASN.0000089828.73014.C8 Kunz, 1997, Platelet-derived growth factor and fibroblast growth factor differentially regulate interleukin 1beta- and cAMP-induced nitric oxide synthase expression in rat renal mesangial cells, J. Clin. Invest., 100, 2800, 10.1172/JCI119827 Goppelt-Struebe, 1996, Regulation of platelet-derived growth factor isoform-mediated expression of prostaglandin G/H synthase in mesangial cells, Kidney Int., 50, 71, 10.1038/ki.1996.288 Hayama, 2002, ERK and p38 MAP kinase are involved in arachidonic acid release induced by H(2)O(2) and PDGF in mesangial cells, Am. J. Physiol. Renal. Physiol., 282, F485, 10.1152/ajprenal.00210.2001 Huwiler, 1995, Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: comparison of hypertrophic and hyperplastic agonists, Biochem. J., 305, 777, 10.1042/bj3050777 Murphy, 2002, Molecular interpretation of ERK signal duration by immediate early gene products, Nat. Cell Biol., 4, 556, 10.1038/ncb822 Choudhury, 2000, Activation of PLC and PI 3 kinase by PDGF receptor alpha is not sufficient for mitogenesis and migration in mesangial cells, Kidney Int., 57, 908, 10.1046/j.1523-1755.2000.00907.x Inaba, 1996, Enhanced expression of platelet-derived growth factor-beta receptor by high glucose. Involvement of platelet-derived growth factor in diabetic angiopathy, Diabetes, 45, 507, 10.2337/diabetes.45.4.507 Powell, 1999, Myofibroblasts. II. Intestinal subepithelial myofibroblasts, Am. J. Physiol., 277, C183, 10.1152/ajpcell.1999.277.2.C183 Chowdhury, 1996, Growth factor mRNA expression in normal colorectal mucosa and in uninvolved mucosa from ulcerative colitis patients, J. Gastroenterol., 31, 353, 10.1007/BF02355024 Leeb, 2002, Regulation of migration of human colonic myofibroblasts, Growth Factors, 20, 81, 10.1080/08977190290031941 Andoh, 2002, Intestinal subepithelial myofibroblasts in inflammatory bowel diseases, J. Gastroenterol., 37, 33, 10.1007/BF03326410 Karlsson, 2000, Abnormal gastrointestinal development in PDGF-A and PDGFR-(alpha) deficient mice implicates a novel mesenchymal structure with putative instructive properties in villus morphogenesis, Development, 127, 3457, 10.1242/dev.127.16.3457 Simm, 1998, Mitogenic effect of PDGF-AA on cardiac fibroblasts, Basic Res. Cardiol., 93, 40, 10.1007/s003950050209 Shindo, 2002, Kruppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling, Nat. Med., 8, 856, 10.1038/nm738 Diez, 2001, Down-regulation of Akt/PKB in senescent cardiac fibroblasts impairs PDGF-induced cell proliferation, Cardiovasc. Res., 49, 731, 10.1016/S0008-6363(00)00296-0 Ponten, 2003, Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy, Am. J. Pathol., 163, 673, 10.1016/S0002-9440(10)63694-2 Reilly, 1998, Pathogenesis and management of idiopathic myelofibrosis, Baillieres Clin. Haematol., 11, 751, 10.1016/S0950-3536(98)80037-1 Caenazzo, 1989, Changes in the mitogenic activity of platelet-derived growth factor(s) in patients with myeloproliferative disease, Acta Haematol., 81, 131, 10.1159/000205544 Martyre, 1991, Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia, Br. J. Haematol., 77, 80, 10.1111/j.1365-2141.1991.tb07952.x Kitagawa, 1994, Immunolocalization of platelet-derived growth factor, transforming growth factor-beta, and fibronectin in acute megakaryoblastic leukemia manifesting tumor formation, Hum. Pathol., 25, 723, 10.1016/0046-8177(94)90307-7 Kimura, 1995, Platelet derived growth factor expression, myelofibrosis and chronic myelogenous leukemia, Leuk. Lymphoma, 18, 237, 10.3109/10428199509059613 Wickenhauser, 1995, Detection and quantification of transforming growth factor beta (TGF-beta) and platelet-derived growth factor (PDGF) release by normal human megakaryocytes, Leukemia, 9, 310 Katoh, 1990, Platelet derived growth factor messenger RNA is increased in bone marrow megakaryocytes in patients with myeloproliferative disorders, Am. J. Hematol., 35, 145, 10.1002/ajh.2830350302 Vannucchi, 2002, Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1(low) mice), Blood, 100, 1123, 10.1182/blood-2002-06-1913 Bonner, 1989, Alpha-macroglobulin secreted by alveolar macrophages serves as a binding protein for a macrophage-derived homologue of platelet-derived growth factor, Am. J. Respir. Cell. Mol. Biol., 1, 171, 10.1165/ajrcmb/1.3.171 Bonner, 1992, Reversible binding of platelet-derived growth factor-AA, -AB, and -BB isoforms to a similar site on the “slow” and “fast” conformations of alpha 2-macroglobulin, J. Biol. Chem., 267, 12837, 10.1016/S0021-9258(18)42352-6 Bonner, 1995, Differential binding and regulation of platelet-derived growth factor A and B chain isoforms by alpha 2-macroglobulin, J. Biol. Chem., 270, 16236, 10.1074/jbc.270.27.16236 Bonner, 1995, Inhibition of platelet-derived growth factor-BB-induced fibroblast proliferation by plasmin-activated alpha 2-macroglobulin is mediated via an alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein-dependent mechanism, J. Biol. Chem., 270, 6389, 10.1074/jbc.270.11.6389 Gonias, 2000, Identical or overlapping sequences in the primary structure of human alpha(2)-macroglobulin are responsible for the binding of nerve growth factor-beta, platelet-derived growth factor-BB, and transforming growth factor-beta, J. Biol. Chem., 275, 5826, 10.1074/jbc.275.8.5826 Wu, 1998, Oxidized alpha2-macroglobulin (alpha2M) differentially regulates receptor binding by cytokines/growth factors: implications for tissue injury and repair mechanisms in inflammation, J. Immunol., 161, 4356, 10.4049/jimmunol.161.8.4356 Brekken, 2001, SPARC, a matricellular protein: at the crossroads of cell-matrix communication, Matrix Biol., 19, 816, 10.1016/S0945-053X(00)00133-5 Raines, 1992, The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors, Proc. Natl. Acad. Sci. U.S.A., 89, 1281, 10.1073/pnas.89.4.1281 Pichler, 1996, SPARC is expressed in renal interstitial fibrosis and in renal vascular injury, Kidney Int., 50, 1978, 10.1038/ki.1996.520 Pichler, 1996, SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-mediated mesangial cell proliferation in vitro, Am. J. Pathol., 148, 1153 Pollock, 1992, The alternative-splice isoforms of the PDGF A-chain differ in their ability to associate with the extracellular matrix and to bind heparin in vitro, Growth Factors, 7, 267, 10.3109/08977199209046409 Raines, 1992, Compartmentalization of PDGF on extracellular binding sites dependent on exon-6-encoded sequences, J. Cell Biol., 116, 533, 10.1083/jcb.116.2.533 Kelly, 1993, Accumulation of PDGF B and cell-binding forms of PDGF A in the extracellular matrix, J. Cell Biol., 121, 1153, 10.1083/jcb.121.5.1153 Somasundaram, 1996, Type I, II, IV, and VI collagens serve as extracellular ligands for the isoforms of platelet-derived growth factor (AA, BB, and AB), J. Biol. Chem., 271, 26884, 10.1074/jbc.271.43.26884 Albanis, 2001, Hepatic fibrosis. Pathogenesis and principles of therapy, Clin. Liver Dis., 5, 315, 10.1016/S1089-3261(05)70168-9 King, 2000, Idiopathic pulmonary fibrosis: diagnosis and management: international consensus statement, Am. J. Respir. Crit. Care Med, 161, 646, 10.1164/ajrccm.161.2.ats3-00 Kraft, 2001, IL-4, IL-13, and dexamethasone augment fibroblast proliferation in asthma, J. Allergy Clin. Immunol., 107, 602, 10.1067/mai.2001.113760 Haynes, 1992, Dexamethasone-induced increase in platelet-derived growth factor (B) mRNA in human alveolar macrophages and myelomonocytic HL60 macrophage-like cells, Am. J. Respir. Cell. Mol. Biol., 7, 198, 10.1165/ajrcmb/7.2.198 Warshamana, 1998, Related articles, links free full text dexamethasone activates expression of the PDGF-alpha receptor and induces lung fibroblast proliferation, Am. J. Physiol., 274, L499 Badgett, 1996, Interferon-gamma modulates lung macrophage production of PDGF-BB and fibroblast growth, J. Lipid Mediat. Cell Signal, 13, 89, 10.1016/0929-7855(95)00048-8 Ziesche, 1999, A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis, N. Engl. J. Med., 341, 1264, 10.1056/NEJM199910213411703 Heis-Vahidi-Fard, 2001, Ineffectiveness of interferon-gamma in the treatment of idiopathic myelofibrosis: a pilot study, Ann. Hematol., 80, 79, 10.1007/s002770000231 Marra, 1996, Interferon-gamma-mediated activation of STAT1alpha regulates growth factor-induced mitogenesis, J. Clin. Invest., 98, 1218, 10.1172/JCI118905 Toyonaga, 1994, Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver, Proc. Natl. Acad. Sci. U.S.A., 91, 614, 10.1073/pnas.91.2.614 Di Sario, 2002, Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production, J. Hepatol., 37, 584, 10.1016/S0168-8278(02)00245-3 Gurujeyalakshmi, 1999, Pirfenidone inhibits PDGF isoforms in bleomycin hamster model of lung fibrosis at the translational level, Am. J. Physiol., 276, L311 Caligiuri, 2003, Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells, Gastroenterology, 124, 504, 10.1053/gast.2003.50058 Shimizu, 2003, Activated protein C inhibits the expression of platelet-derived growth factor in the lung, Am. J. Respir. Crit. Care Med., 167, 1416, 10.1164/rccm.200206-515OC Rice, 1999, Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats, Am. J. Pathol., 155, 213, 10.1016/S0002-9440(10)65115-2 Savikko, 2003, Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy, Transplantation, 75, 1147, 10.1097/01.TP.0000062836.93496.CE Beham-Schmid, 2002, Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis, Blood, 99, 381, 10.1182/blood.V99.1.381